Insider Transactions in Q4 2020 at Aligos Therapeutics, Inc. (ALGS)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 20
2020
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,906,191
+36.53%
|
-
|
|
Oct 20
2020
|
Novo Holdings > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
200,000
+7.11%
|
$3,000,000
$15.0 P/Share
|
|
Oct 20
2020
|
Novo Holdings > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,414,563
+50.0%
|
-
|
|
Oct 20
2020
|
Leonid Beigelman President |
BUY
Conversion of derivative security
|
Indirect |
273,057
+25.02%
|
-
|
|
Oct 20
2020
|
Lawrence Blatt Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
273,058
+29.94%
|
-
|
|
Oct 20
2020
|
Carole Nuechterlein |
BUY
Conversion of derivative security
|
Indirect |
3,092,340
+25.83%
|
-
|
|
Oct 20
2020
|
Lucinda Y. Quan |
BUY
Conversion of derivative security
|
Indirect |
9,258
+24.62%
|
-
|
|
Oct 20
2020
|
Julian A. Symons |
BUY
Conversion of derivative security
|
Direct |
18,517
+1.54%
|
-
|
|
Oct 20
2020
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
200,000
+18.82%
|
$3,000,000
$15.0 P/Share
|
|
Oct 20
2020
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
662,444
+36.53%
|
-
|
|
Oct 20
2020
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,429,895
+20.4%
|
-
|
|
Oct 20
2020
|
Vivo Capital Viii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
550,000
+13.42%
|
$8,250,000
$15.0 P/Share
|
|
Oct 20
2020
|
Vivo Capital Viii, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,997,030
+25.23%
|
-
|
|
Oct 20
2020
|
Thomas Woiwode Director |
BUY
Open market or private purchase
|
Indirect |
200,000
+18.82%
|
$3,000,000
$15.0 P/Share
|
|
Oct 20
2020
|
Thomas Woiwode Director |
BUY
Conversion of derivative security
|
Indirect |
3,092,339
+26.85%
|
-
|